Stephanie Amaru

Apr 15, 2024 | jdsupra.com | Stephanie Amaru |Reza Zarghamee

As regulation of the use of PFAS in consumer products continues to develop at a rapid pace in the United States, businesses that manufacture or sell products internationally should also keep their fingers on the pulse of foreign regulatory developments. On April 4, members of the French Parliament unanimously approved a bill calling for the ban on the manufacture, import and sale of certain products containing per- and polyfluoroalkyl substances (PFAS), starting January 1, 2026.

Aug 28, 2023 | jdsupra.com | Stephanie Amaru |Reza Zarghamee

On August 17, 2023, the U.S. Environmental Protection Agency (EPA) released preliminary results from the fifth Unregulated Contaminant Monitoring Rule (UCMR) under Section 1445(a)(2) of the Safe Drinking Water Act (SDWA). The UCMR provides a mechanism for the EPA to collect data regarding impacts to public water systems from “emerging contaminants,” for which the SDWA does not otherwise require sampling and mitigation.

May 8, 2023 | jdsupra.com | Stephanie Amaru |Reza Zarghamee

Partly driven by recent litigation involving the presence of PFAS in cosmetics, the Modernization of Cosmetics Regulation Act (MoCRA) of 2022 mandates more stringent FDA regulation of companies that manufacture cosmetics and imposes information submission requirements that could serve as the basis for regulatory enforcement and litigation.

Apr 21, 2023 | pillsburylaw.com | Reza Zarghamee |Stephanie Amaru

Takeaways The enactment of the Modernization of Cosmetics Regulation Act (MoCRA) significantly expands U.S. Food and Drug Administration (FDA) rulemaking and enforcement authority over cosmetic products and inputs. The FDA will assess the presence and health risks associated with PFAS in cosmetics over the next three years, signaling an increased interest in regulating the use of PFAS in cosmetics.